These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9049488

  • 41. Development of diabetic nephropathy in Japanese patients with insulin-dependent diabetes mellitus: Tokyo Women's Medical College epidemiologic study.
    Yokoyama H, Uchigata Y, Otani T, Maruyama A, Yano-Aoki K, Kanematsu S, Kasahara T, Matsuura N, Omori Y.
    J Diabetes Complications; 1994; 8(1):7-12. PubMed ID: 8167391
    [Abstract] [Full Text] [Related]

  • 42. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM.
    Sundkvist G, Lilja B.
    Diabetes Care; 1993 May; 16(5):773-9. PubMed ID: 8495619
    [Abstract] [Full Text] [Related]

  • 43. Glomerular volume and the glomerular vascular pole area in patients with insulin-dependent diabetes mellitus.
    Osterby R, Asplund J, Bangstad HJ, Nyberg G, Rudberg S, Viberti G, Walker JD.
    Virchows Arch; 1997 Nov; 431(5):351-7. PubMed ID: 9463577
    [Abstract] [Full Text] [Related]

  • 44. Stabilization of glomerular filtration rate over 2 years in patients with diabetic nephropathy under intensified therapy regimens. Diabetes Treatment and Teaching Programmes Working Group.
    Sawicki PT.
    Nephrol Dial Transplant; 1997 Sep; 12(9):1890-9. PubMed ID: 9306340
    [Abstract] [Full Text] [Related]

  • 45. Renal size and function in diabetic nephropathy.
    Avram MM, Hurtado H.
    Nephron; 1989 Sep; 52(3):259-61. PubMed ID: 2739865
    [Abstract] [Full Text] [Related]

  • 46. Skin blood cell flux in insulin-dependent diabetic subjects in relation to retinopathy or incipient nephropathy.
    Houben AJ, Schaper NC, Slaaf DW, Tangelder GJ, Nieuwenhuijzen Kruseman AC.
    Eur J Clin Invest; 1992 Jan; 22(1):67-72. PubMed ID: 1559544
    [Abstract] [Full Text] [Related]

  • 47. The progression of diabetic nephropathy in type I diabetics: relationship to metabolic control and blood pressure.
    Zander E, Schulz B, Mester J, Jutzi E, Templin R, Conde N.
    J Diabet Complications; 1987 Jan; 1(2):53-7. PubMed ID: 2969902
    [Abstract] [Full Text] [Related]

  • 48. Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM.
    Barzilay J, Warram JH, Bak M, Laffel LM, Canessa M, Krolewski AS.
    Kidney Int; 1992 Apr; 41(4):723-30. PubMed ID: 1513093
    [Abstract] [Full Text] [Related]

  • 49. The quantitative relationship between treated blood pressure and progression of diabetic renal disease.
    Dillon JJ.
    Am J Kidney Dis; 1993 Dec; 22(6):798-802. PubMed ID: 8250025
    [Abstract] [Full Text] [Related]

  • 50. Clinical features and health-care costs of diabetic nephropathy.
    Narins BE, Narins RG.
    Diabetes Care; 1988 Dec; 11(10):833-9. PubMed ID: 3073074
    [Abstract] [Full Text] [Related]

  • 51. [Prolactin secretion in diabetic nephropathy of patients with diabetes mellitus type I (IDDM)].
    Zukowska-Szczechowska E, Moczulski D, Grzeszczak W, Gumprecht J.
    Pol Arch Med Wewn; 1996 Feb; 95(2):125-34. PubMed ID: 8677206
    [Abstract] [Full Text] [Related]

  • 52. Impact of metabolic control in progression of clinical diabetic nephropathy.
    Nyberg G, Blohmé G, Nordén G.
    Diabetologia; 1987 Feb; 30(2):82-6. PubMed ID: 3106126
    [Abstract] [Full Text] [Related]

  • 53. Platelet Na+/H+ antiport activity in patients with insulin-dependent diabetes mellitus with and without diabetic nephropathy.
    Düsing R, Sorger M, Mattes L, Göbel BO, Hoffmann G, Rosskopf D, Vetter H, Siffert W.
    Clin Investig; 1993 Feb; 71(2):119-25. PubMed ID: 8384910
    [Abstract] [Full Text] [Related]

  • 54. Glutathione reverses the growth abnormalities of skin fibroblasts from insulin-dependent diabetic patients with nephropathy.
    Morocutti A, Sethi M, Hayward A, Lee A, Viberti G.
    J Am Soc Nephrol; 1998 Jun; 9(6):1060-6. PubMed ID: 9621289
    [Abstract] [Full Text] [Related]

  • 55. Lack of association between cystopathy and progression of diabetic nephropathy in insulin-dependent diabetes mellitus.
    Torffvit O, Agardh CD, Mattiasson A.
    Scand J Urol Nephrol; 1997 Aug; 31(4):365-9. PubMed ID: 9290167
    [Abstract] [Full Text] [Related]

  • 56. Relationships of cell proliferation and expression of integrin subunits and type I collagen in skin fibroblasts with renal lesions in patients with IDDM.
    Jin DK, Kim Y, Mauer M, Fioretto P, Vats A, Fish AJ.
    Am J Kidney Dis; 1998 Feb; 31(2):293-300. PubMed ID: 9469500
    [Abstract] [Full Text] [Related]

  • 57. A basis for accelerated progression of diabetic nephropathy in Pima Indians.
    Lemley KV.
    Kidney Int Suppl; 2003 Feb; (83):S38-42. PubMed ID: 12864873
    [Abstract] [Full Text] [Related]

  • 58. Urinary excretion of the carboxy terminal domain of type IV collagen is associated with kidney size and function in IDDM.
    Torffvit O, Wieslander J, Forsberg L, Hederström E, Agardh CD.
    J Diabet Complications; 1990 Feb; 4(4):166-9. PubMed ID: 2151228
    [Abstract] [Full Text] [Related]

  • 59. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group.
    Breyer JA, Bain RP, Evans JK, Nahman NS, Lewis EJ, Cooper M, McGill J, Berl T.
    Kidney Int; 1996 Nov; 50(5):1651-8. PubMed ID: 8914032
    [Abstract] [Full Text] [Related]

  • 60. Different expression of fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy.
    Gianazza E, Mainini V, Castoldi G, Chinello C, Zerbini G, Bianchi C, Galbusera C, Stella A, Mauri G, Zoppis I, Magni F, Kienle MG.
    J Proteomics; 2010 Jan 03; 73(3):593-601. PubMed ID: 19631771
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.